Identification of Immune Responsive Genes in Bovine Airway Using Suppression Subtractive Hybridization by Cai, Yibin
Identification of Immune Responsive 
Genes in Bovine Airway Using 
Suppression Subtractive Hybridization 
 
 
 
   By 
   YIBIN CAI 
   Bachelor of Engineering 
East China University of Science and Technology 
Shanghai, China 
1997 
 
 
 
   Submitted to the Faculty of the 
   Graduate College of the 
   Oklahoma State University 
   in partial fulfillment of 
   the requirements for 
   the Degree of 
   MASTER OF SCIENCE  
December, 2006 
Identification of Immune Responsive 
Genes in Bovine Airway Using 
Suppression Subtractive Hybridization 
 
 
 
 
 
   Thesis Approved: 
 
 
Dr. Guolong Zhang 
   Thesis Adviser 
 
Dr. Rodney Geisert    
 
Dr. Udaya DeSilva 
 
Dr. A. Gordon Emslie 
   Dean of the Graduate College
 ii
 ACKNOWLEDGMENTS 
 
I would like to express my great gratitude to my thesis advisor, Dr. Guolong Zhang, 
for his intelligent supervision, constructive guidance, and encouragement throughout my 
graduate program during last two and a half years. I would also like to thank the other 
two of my supervisory committee members, Drs. Rodney Geisert, and Udaya DeSilva for 
their patience, support, and guidance.  
I am grateful for the help, support and friendship from all the members in our lab, 
Yanjing Xiao, Amar Patil, and Yugendar Bommineni.  
I am deeply indebted to my family for their love and encouragement. My parents, 
Shanyu Cai and Fen Hu, and my sister Yiying Cai, always support my pursuit of higher 
education and training. My appreciation also extends to all of my friends for their 
encouragement and friendship. I deeply appreciate the love of my grandmother, Genbao 
Xu, who brought me up and motivated me. 
 
 
 
 
 
 iii
TABLE OF CONTENTS 
 
Chapter          Page 
 
I. INTRODUCTION......................................................................................................1 
 
II. REVIEW OF LITERATURE 
 1.    Bovine Respiratory Disease (RBD) Complex ..................................................3 
 1.1. Pathogenesis of BRD ........................................................................................3 
 1.2. Virulence factors of M. haemolytica.................................................................3 
 1.3. Host defense factors in the bovine airway ........................................................5 
 1.4. Current therapeutics against BRD ....................................................................6 
 2.    Identification of Immune Responsive Genes by Differential 
   mRNA Expression Techniques ........................................................................8 
 2.1. Suppression subtractive hybridization (SSH)  .................................................9 
 2.2. Serial analysis of gene expression (SAGE) ......................................................9 
 2.3. DNA microarray ...............................................................................................9 
 
III. MATERIALS AND METHODS 
 1.   Suppression subtractive hybridization (SSH) procedure .................................11 
 2.   Optimization of the infective dose of M. haemolytica to  
 bovine airway cells .........................................................................................12 
 3.   Identification of differentially expressed genes in response to 
 infections with M. haemolytica .......................................................................13 
 4. Identification of bovine lung-specific transcripts by SSH...............................14 
 5. Confirmation of the SSH result by RT-PCR....................................................15 
  
 
IV. RESULTS..............................................................................................................17 
 
 1. Determination of the optimal infective dose of M. haemolytica .....................18 
 2. Identification of inducible genes in response to infections with  
M. haemolytica    .............................................................................................19 
 3. Identification of bovine lung-specific transcripts by SSH...............................20 
 4. Confirmation of the SSH result by RT-PCR....................................................21 
 
 
V.  DISCUSSION ........................................................................................................22 
REFERENCES ............................................................................................................26 
TABLES AND FIGURES ...........................................................................................34 
 
 
 
 
 iv
 
LIST OF TABLES 
 
Table                                    Page 
 
Table 1. Summary of sequencing and BLAST results.................................................34 
 
Table 2. Primers for semi-quantitative and real-time RT-PCR ...................................35 
 
Table 3. M. haemolytica-induced genes in BT cells identified by SSH ......................36 
 
Table 4. M. haemolytica-induced genes in EBTr cells identified by SSH ..................38 
 
Table 5. Lung-specific genes identified by SSH .........................................................39 
 
 
                                                                                                                                     
 
 
 
 v
 
 
 
 
 
LIST OF FIGURES 
Figure                                                                                                                          Page 
 
Fig. 1. Growth curve of M. haemolytica.  ...................................................................41 
 
Fig. 2. Semi-quantitative RT-PCR Analysis of IL-6 mRNA expression in BT and  
      EBTr cells following an infection with different doses of M. haemolytica......42 
 
Fig. 3. Determination of the optimal cycle number for linear cDNA amplification. ..43 
 
Fig. 4. Analysis of cDNA recovered from BD CHROMA SPIN 1000 columns.........44 
 
Fig. 5. Analysis of subtracted cDNA samples by gel electrophoresis .........................45 
 
Fig. 6. Analysis of the subtraction efficiency ..............................................................46 
 
Fig. 7. Screening of the inserts by colony PCR ...........................................................47 
 
Fig. 8. Rearrangement of the inserts based on their sizes............................................48 
 
Fig. 9. Semi-quantitative RT-PCR confirmation of four M. haemolytica-  
      induced genes identified by SSH ......................................................................49 
 
Fig. 10. Real-time RT-PCR confirmation of four M. haemolytica-induced  
           genes identified by SSH....................................................................................50 
 vi
 
 
 
 
 
CHAPTER I 
 
INTRODUCTION 
 
The bovine respiratory disease (BRD) complex is a major cause of the morbidity and 
economic loss in the cattle industry in North America. The pathogenesis of BRD is a 
complex process associated with many bacterial and viral agents. Mannheimia 
haemolytica has been identified as the primary bacterial strain that contributes to BRD in 
the last few decades. The binding of leukotoxin produced by M. haemolytica and β2-
integrin (CD11/CD18) of macrophages and neutrophils results in the activation and lysis 
of these inflammatory cells, which in turn leads to severe damages of bovine airway 
tissues. 
In recent years, several differential gene expression techniques, including DNA 
microarray, suppression subtractive hybridization (SSH), and serial analysis of gene 
expression (SAGE), have been developed to analyze transcriptional changes and identify 
immune responsive genes in response to different infections. In this study, we employed 
SSH to search for the genes that are up-regulated following stimulation of bovine 
turbinate and tracheal cell lines with M. haemolytica as well as the genes that are 
specifically expressed in bovine lung. As a result, we have identified a total of 116 non-
redundant genes that are induced in BT and EBTr cells following infection and 61 non-
redundant lung-specific genes. Semi-quantitative and real-time PCR was used to further 
confirm the expression patterns of six randomly selected genes. Identification and 
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detailed analysis of these genes will facilitate our understanding of the host defense 
mechanisms in the bovine airway as well as the development of novel therapeutics 
against M. haemolytica.
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CHAPTER II 
 
REVIEW OF LITERATURE 
 
1. Bovine Respiratory Disease (BRD) Complex  
 
1.1. Pathogenesis of BRD  
The BRD complex, also known as bovine pneumonic pasteurellosis (BPP) or 
shipping fever, is one of the major diseases that cause significant economic losses in both 
the feedlot and dairy cattle industry [1, 2]. Approximately 75% of morbidity and 50% of 
mortality in the feedlot were caused by BRD [3], with annual of over $3 billion for 
prevention and treatment in the US [4].  
BRD is characterized by interlobular and interalveolar fibrosis and cellular influx of 
neutrophils into the lung of infected cattle [5, 6]. The inflammatory may prolong to 
pleural surface in some severe infections [6].  
BRD has been found to be associated with a number of bacteria (such as Mannheimia 
haemolytica, Pasteurella multocida, Haemophilus somnus, and Mycoplasma spp.) and 
viruses (such as infectious bovine rhinotracheitis virus, bovine viral diarrhea virus, 
parainfluenza virus 3, and bovine respiratory syncytial virus) [7]. Among all of the 
pathogens, M. haemolytica is the most important bacterial agent responsible for the 
symptoms and pathogenesis of BRD [1]. 
 
1.2. Virulence factors of M. haemolytica  
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M. haemolytica is a weakly hemolytic, Gram-negative coccobacillus. There are a total 
of 12 serotypes of M. haemolytica that have been identified. Serotype 1 (A1) does not 
colonize well in the upper respiratory tract of health cattle. However, the environmental 
stresses, such as shipping, weaning, overcrowding and infection of other pathogens, can 
change the situation. Once proliferating in the upper respiratory tract, M. haemolytica A1 
comes into the lower airway and invades sloughed cells and tissues [1-3]. 
Several components of M. haemolytica have been identified as virulence factors 
involved in BRD, including leukotoxin (Lkt), lipopolysaccharide (LPS), capsule, outer 
membrane proteins, adhesins, and neuraminidase. Among them, Lkt and LPS are the 
primary factors to provoke inflammatory responses and cause lesions of the cells in the 
bovine airway [2, 8]. 
Lkt is known to cause severe lesions of bovine lung in BRD. Being a water-soluble 
and pH-stable glycoprotein of 102-kDa, Lkt is secreted by M. haemolytica during the 
logarithmic phase of growth [2, 8]. It is a pore-forming toxin with six peptide repeats, 
belonging to the RTX (repeats in toxin) family of multidomain exotoxin [8]. At high 
concentrations, Lkt can form pores on the membrane of bovine leukocytes and cause the 
release of the toxic components [5, 9]; while at lower concentrations, Lkt acts as a 
neutrophil chemoattractant and further stimulates neutrophil degranulation [5]. Cattle 
infected with Lkt-deficient M. haemolytica or inactive Lkt have reduced pathology, 
which is consistent with the important role of Lkt in BRD pathogenesis [5]. 
LPS, one of the major components of Gram-negative bacterial cell wall, can 
recognize and bind to several host receptors, such as membrane CD14, toll-like receptors, 
and β2-integrins. M. haemolytica LPS is known to cause lesions on bovine lung 
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endothelial cells, while protecting Lkt from degradation by associating with it, which in 
turn increases the severity of the damage to bovine airway cells [2]. 
 
1.3. Host defense factors in the bovine airway 
Several innate host defense factors, including mucosal surface, bronchoalveolar 
macrophages (BAM), and neutrophils, have been well recognized in defense against the 
BRD pathogens. Mucosal surface, as a physical barrier of the bovine respiratory tract, can 
filter the air and remove the particles larger than 5 µm before they come into the lung. 
The mucous on the mucosal surface has antimicrobial functions, containing secretory Ig 
A, lysozyme as well as a host of other factors. BAM and neutrophils kill pathogens by 
phagocytosis and release of inflammatory cytokines and host defense molecules [9]. 
β2-integrins are a group of heterodimeric membrane proteins containing α (CD11a, -
b, -c, or d) and β (CD18) subunits and function as adhesion molecules in leukocyte 
migration [12]. Lkt produced by M. haemolytica can bind to macrophages and 
neutrophils through a type of β2-integrins, namely LFA-1 (CD11a/CD18). Insertion of 
Lkt into the cell membrane to form a hydrophilic pore leads to lysis of these 
inflammatory cells through the efflux of K+ and influx of Ca2+. Subsequently, the release 
of toxic compounds from these cells causes severe pulmonary lesions.  
Several cytokines, such as IL-1β, IL-8 and IFN-γ produced from activated 
macrophages and neutrophils, function as proinflammatory factors to exacerbate the 
pathology by enhancing the expression of β2-integrins on bovine leukocytes and 
susceptibility of these cells to Lkt [1].  Pulmonary expression of IL-1β, IL-8 and TNF-α 
was also suggested to be responsible for lung lesions in BRD [13]. Platelet-activating 
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factor (PAF), which was found to mediate the vascular permeability and neutrophil 
activation in the lung of the BRD cattle in the first few hours of infection, may also be 
associated with the pulmonary injury [14]. Furthermore, production of nitric oxide (NO) 
by activated BAMs following M. haemolytica infection may also play an important role 
in mediating the pathogenesis of pulmonary lesions in BRD [16]. 
It has been revealed recently that bovine herpsvirus-1 (BHV-1) infection leads to the 
release of inflammatory cytokines, such as IL-1β, TNF-α and IFN-γ, which in turn 
increases the expression of LFA-1 in bovine peripheral blood mononuclear cells [15]. 
This may explain why cattle infected with BHV-1 are more susceptible to subsequent M. 
haemolytica infections. 
Maternally and naturally acquired antibodies against M. haemolytia and P. multocida 
in beef calves were studied. IgM, IgG1and IgG2 that recognize Lkt and entire cells of M. 
haemolytia and outer membrane P. multocida proteins (OPMs) have been detected [11]. 
The data suggested that the calves start to produce antibodies against M. haemolytia and 
P. multocida about 60-90 days of age and the best timing for vaccinating beef calves is 4 
months of age [11]. 
 
1.4. Current therapeutics against BRD 
Antimicrobial agents, including tylosin, erythromycin, tetracycline and penicillin, 
have been used in the therapy of BRD for decades. Recently, several new antimicrobials, 
such as tilmicosin phosphate, florfenicol and enrofloxacin, were used to treat the cattle 
with BRD. However, the resistance of bacteria to these antimicrobial has been well 
documented [17]. 
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A novel antimicrobial, tulathromycin, was developed more recently and displayed a 
higher efficiency than tilmicosin and florfenicol in the treatment of BRD in stock cattle 
and cattle at high risk of developing undifferentiated BRD [18-21]. Although 
tulathromycin-resistant bacteria have not been reported, it’s almost certain that the 
resistance will develop just like other traditional antimicrobial agents after being applied 
extensively.    
To reduce the likelihood of the development of antibiotic resistance, the potential of a 
new class of membrane-active, peptide antimicrobials in the BRD treatment has been 
explored. For example, an antibacterial peptide, cecropin B, was over-expressed on 
bovine nasal mucosa and found to inhibit the colonization of M. haemolytica on nasal 
mucosa in vivo [22]. 
Vaccines are also widely used in the prevention of BRD. Inactivated BRD pathogens 
or their structural components have been used as antigens to elicit humoral immunity in 
cattle [23, 24]. An edible vaccine has been developed by using transgenic plants. 
Expression of a M. haemolytica A1 Lkt derivative in white cover was able to elicit the 
production of anti-Lkt neutralizing antibodies in rabbits [25]. The effectiveness of this 
vaccine in cattle is yet to be tested [25]. 
Oral administration of BRD-infected cattle with natural human interferon-α (nHuIFN-
α) revealed that nHuIFN-α decreased the occurrence of sick animals and postponed the 
development of BRD [27]. A study with recombinant interleukin-1β suggested that IL-1β 
could be used as a vaccine adjuvant (rbIL-1β) at least in BHV-1/M. haemolytica co-
infected cattle [26]. 
. 
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Collectively, in spite of numerous attempts in the prevention and treatment of the 
BRD complex in the cattle, there are still no highly effective agents or strategies available 
to date. Not surprisingly, BRD remains a major economic threat to the cattle industry.  
There is an urgent need to develop more effective therapeutic strategies against the BRD 
complex.  
 
2. Identification of Immune Responsive Genes by Differential mRNA Expression 
Techniques 
A variety of techniques have been developed and applied to the identification of 
differentially expressed genes following infections of animals or immune cells with 
different pathogens. Among them, suppression subtractive hybridization (SSH), serial 
analysis of gene expression (SAGE), and DNA microarray are the most commonly used. 
  
2.1. Suppression subtractive hybridization (SSH) 
In SSH, two populations of cDNAs (tester and driver) are compared and the 
differentially transcript genes are displayed in a subtracted cDNA library [28]. SSH has 
been widely employed in the identification of differentially expressed genes involved in 
immune responses. For example, a total of 87 genes were identified in a screening of up-
regulated genes in mouse spleen cells following stimulation with immunostimulatory 
oligodeoxyribo-nucleotides by using SSH [29]. A novel murine CC chemokine gene, 
namely ABCD-1 was isolated using SSH by challenging the pro/pre B cells with anti-
CD40 and IL-4 [31]. By using SSH, a new kinase, IKK-i was identified to be up-
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regulated in response to stimulation of mouse macrophage cell line RAW264.7 with LPS 
[32]. SSH was also employed to search for new antigens in a cancer vaccine study [34]. 
 
2.2. Serial analysis of gene expression (SAGE) 
SAGE was used in study of the protein function in eukaryotes.  10-14 bp cDNA tags 
were concatemerized for sequencing, and the result was analyzed in the database. This 
technique can be used for identification and quantification of gene expression [28]. 
SAGE has been applied to study the transcriptional profiles of activated Th1 and Th2 
cells from human cord blood leukocytes [35]. A number of differentially expressed genes 
were also identified following the stimulation of human monocytes with LPS [36]. In a 
study of bovine B lymphocytes in the follicles of Peyer's patches, the gene expression 
pattern was obtained using SAGE, and the result was further confirmed in functional 
studies [37]. 
 
2.3. DNA microarray 
DNA microarray is used to display the global expression profile of a cell. However, 
it’s relative expensive and not good at searching for novel gene [28]. A limited DNA 
microarray was employed to define the gene expression profile of the chemokine and 
chemokine receptor family, cytokines, and signaling pathways in human bronchial 
epithelial cells in response to different toll-like receptor agonists [38]. The results 
indicated the TLR signaling may play an important role in the airway defense against 
inhaled pathogens. DNA microarray was also applied to investigate gene expression 
changes in human alveolar epithelial cells in response to microbial products and 
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proinflammatory cytokines including LPS and TNF-α [39]. The results showed that 
alveolar epithelial cells have distinct immune responses to different stimuli and 
presumably play an important role in lung defense. To study the innate immune system of 
the trout, monocytes were isolated and stimulated with LPS or LPS plus cortisol, 1380 
genes were analyzed using microarray, and differential gene expression patterns have 
been revealed between two treatments [40]. 
SSH and DNA microarray were also combined together to identify immune 
responsive genes, in which differentially expressed genes were screened first using SSH 
and further confirmed by DNA microarray. For example, by using a combination of SSH, 
microarray and Northern blot, a total of 22 genes were identified to be over-expressed in 
murine macrophages following an infection with Yersinia pestis [41]. In another study, 
five up-regulated and 30 down-regulated genes were identified in rat mononuclear cells 
after the animals were exposed to wielding fumes by SSH and DNA microarray [42]. 
 
In this study, we employed SSH to search for the genes that are differentially 
expressed following infection of bovine airway cells with live M. haemolytica. 
Furthermore, SSH was also used to identify a number of genes that are preferentially 
expressed in the bovine lung.  Development of a comprehensive DNA microarray 
featuring lung-specific genes as well as the genes involved in airway immune responses 
will undoubtedly facilitate a better understanding of innate host defense mechanisms in 
the bovine respiratory tract and the development of novel therapeutic strategies against 
the BRD complex.
 10
 
 
 
 
 
CHAPTER III 
 
MATERIALS AND METHODS 
 
1. Suppression subtractive hybridization (SSH) procedure 
Total RNA was isolated from bovine cells and tissues using Tri Reagent (Sigma, St 
Louis, MO). SSH was performed by using the PCR-Select cDNA Subtraction Kit 
following the manufacturer’s recommendations (Clontech, Mountain View, CA). Briefly, 
the first-strand and second-strand cDNA were synthesized, and double-stranded DNA 
was then digested with RsaI at 37°C for 3 h. Digested tester DNA was ligated with 
adaptor 1 (5’-
CTAATACGACTCACTATAGGGCTCGAGCGGCCGCCCGGGCAGGT-3’) and 2R 
(5’-CTAATACGACTCACTATAGGGCAGCGTGGTCGCGGCCGAGGT-3’), whereas 
no ligation is needed for the control driver DNA.  
The testers with adaptor 1 and 2R were hybridized separately with driver DNA for 9 
h, and then two pools were mixed together with 30-fold more driver DNA for another 16 
h. Two rounds of PCR were subsequently performed with diluted DNA mixture to 
preferentially amplify cDNAs that are differentially expressed. The first round of PCR 
involved with the primer 1(5’- CTAATACGACTCACTATAGGGC-3’) for 27 cycles 
and the second round of PCR used nested primer 1 (5’-TCGAGCGGCCGCCCGGGCA 
GGT-3’) and primer 2R (5’-AGCGTGGTCGCGGCCGAGGT-3’) for 10 cycles. 
Similarly diluted unsubtracted testers were also performed with the same two rounds of 
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PCR. To evaluate the efficiency of subtraction, diluted subtracted and unsubtracted 
nested PCR products were further amplified for 20, 25, 30 and 35 cycles by PCR for a 
house-keeping gene, GAPDH, and the products were then analyzed by electrophoresis on 
a 1.2% agarose gel. 
To reveal the identities of differentially expressed genes, subtracted PCR products 
were ligated to pGEM-T-Easy Vector (Promega, Madison, WI) and transformed into 
competent DH-5α cells by electroporation. White colonies were picked randomly on the 
LB agar plates containing ampicillin, IPTG and X-gal after overnight incubation at 37°C. 
Following verification of insertion size by colony PCR, bacterial colonies with different 
insertions were picked up and sequenced directly.  The identities of the genes were 
revealed by BLAST search of the GenBank databases on the National Center for 
Biotechnology Information (NCBI) website (http://www.ncbi.nlm.nih.gov/blast). 
 
2. Optimization of the infective dose of M. haemolytica to bovine airway cells  
M. haemolytica (strain 89010807N; a kind gift from Dr. Anthony Confer in the 
Center for Veterinary Health Sciences at Oklahoma State University) [43] was grown 
overnight in Brain Heart Infusion (BHI) broth at 37°C. To first obtain the growth curve, 
bacteria were inoculated 1:1000 in fresh BHI and grown in a shaking incubator for up to 
7 h.  One ml of aliquots was taken every 1 h and measured for OD600, followed by serial 
dilution of bacterial culture and spreading onto BHI agar plates for overnight growth. 
Viable colonies were counted for each hourly bacterial culture in order to obtain the 
correlation between OD600 and bacterial number.    
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To infect bovine airway cells, overnight bacterial culture was subcultured 1:1000 for 
3-4 h in fresh BHI medium until OD600 reached 0.4- 0.7 (logarithmic phase). The bacteria 
were harvested by centrifuging at 1,000 x g for 10 min, washed with PBS for three times, 
and resuspended in 1.0 ml of PBS on ice for further experiments. Embryonic Bovine 
Tracheal (EBTr) cells and Bovine Turbinate (BT) cells were purchased from ATCC 
(Manassas, VA) and cultured in DMEM containing 10% horse serum in the present of 
5% CO2 at 37°C. Both cell lines were seeded in 6-well plates and allowed to grow 
overnight to 80-90% confluence before infected with M. haemolytica. Different doses of 
live and heat-inactivated bacteria were used to infect cells for 6 h. For heat inactivation, 
bacteria were heated to 60°C for 1 h before adding into the cell culture plates.  
Following bacterial infection, cell culture medium was aspirated and cells were 
washed with PBS for three times. Total RNA was isolated from cells using Tri Reagent 
(Sigma) and the first-strand cDNA was synthesized using Superscript III reverse 
transcriptase (Invitrogen, Carlsbad, CA), and semi-quantitative PCR was used to evaluate 
the expression of interleukin (IL)-6 and IL-8 as described as in former article [44]. The 
bacterial concentration that gave the strongest induction of IL-6 and/or IL-8 was 
determined as the optimal dose for large-scale infections as described below. 
 
3. Identification of differentially expressed genes in response to infection with M. 
haemolytica  
Once the optimal dose of infection (the ratio of pathogen to host cells as 10:1) was 
determined, BT and EBTr cells grown in 150 mm tissue culture plates were infected with 
the optimal dose of live bacteria for 6 h. Total RNA were isolated, and 1 µg of RNA was 
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used for the first-strand cDNA synthesis by using the Super SMART PCR cDNA 
Synthesis Kit (Clontech) with primers (5’-AAGCAGTGGTATCAACGCAGAGTAC T 
(30) VN-3’). The 5’-end of first-strand cDNA was further ligated with 5’-AAGCAGTGG 
TATCAACGCAGAGTACGCGGG-3’. Amplification of the ligated first-strand cDNA 
was performed by PCR with the primer (5’-AAGCAGTGGTATCAA CGCAGAGT-3’). 
To ensure a linear amplification of each sample, different PCR cycles (15, 18, 21 and 24) 
were performed. The highest cycle number before reaching the saturation of the PCR 
product was determined to be the optimal cycle. A large volume PCR was performed by 
using the optimal cycles, and the DNA mixture in the PCR product was further separated 
by size through CHROMA SPIN 1000 Columns (Clontech). Following collection of 
DNA of different size ranges, only the high molecular weight DNA was ligated with 
adaptors and used in SSH as described above with the infected RNA sample as the tester 
and uninfected control sample as the driver.  
After two rounds of subtractive hybridization and PCR amplification, subtracted PCR 
products were ligated into T-easy Vector, transformed into DH5α, and grown in LB agar 
plates containing ampicillin, IPTG and X-gal overnight.  A total of 576 white colonies 
were randomly picked for BT and EBTr cells, and the size of each insertion was verified 
by colony PCR with the primer (5’-TCGAGCGGCCGCCCGGGCAGGT-3’). 192 
colonies with different insertion sizes were picked and sequenced directly. A BLAST 
search through the NCBI databases was performed to reveal the identities of those 
differentially expressed genes.  
 
4. Identification of bovine lung-specific transcripts by SSH 
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To obtain the genes that are specifically expressed in bovine lung, tissue samples 
including lung, heart, liver, muscle, colon, and rumen were collected from a healthy, 1.5-
year-old steer. Total RNA was isolated using Tri Reagent (Sigma), and mRNA was 
further purified using Oligotex (Qiagen). An equal amount of mRNA from heart, liver, 
muscle, colon, and rumen was mixed and used as the driver in subsequent SSH, whereas 
lung mRNA was used as the tester. Double-stranded cDNA were synthesized separately 
from 2 µg of mRNA from lung and other tissues using the PCR-Select cDNA Subtraction 
Kit (Clontech) following the manufacturer’s recommendation as described above. A total 
of 288 white colonies was picked and checked for insert sizes by PCR.  Ninety-six 
colonies containing different insert sizes were sequenced and their identities were 
revealed by BLAST search of the GenBank database. 
 
5. Confirmation of the SSH results by RT-PCR 
To confirm the SSH results, BT and EBTr cells grown in 100 mm plates were 
infected M. haemolytica at the ratio of 10:1 (bacteria:host cell). Cells were then harvested 
at 0, 1, 3, 6 and 12 h post-infection and total RNA was isolated. Sixteen genes that were 
found to be up-regulated in infected BT and EBTr cells by the SSH analysis were 
selected and specific exon-spanning primers were designed (Table 2). Semi-quantitative 
RT-PCR and real-time RT-PCR were used for analysis of gene expression as described 
[44, 45]. 
In semi-quantitative RT-PCR, a total of 1.0 µg RNA from sample were reverse 
transcribed with random hexamers and SuperScript III reverse transcriptase by using a 
first-strand cDNA synthesis kit (Invitrogen) according to the manufacturer’s instructions. 
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The subsequent PCR was carried out with 1/40 of the first-strand cDNA and gene-
specific primers for each putative up-regulated gene and β-actin as described [44]. Every 
pair of primer was designed to locate on different exons to aid in distinguishing PCR 
products amplified from cDNA vs. genomic DNA. The PCR program used was: 94oC 
denaturation for 2 min, followed by different cycles of 94oC denaturation for 20 sec, 
60oC annealing for 20 sec, and 72oC extension for 30 sec, followed by a final extension 
at 72oC for 5 min. The number of PCR cycle was optimized for each gene to ensure 
linear amplification. A half of the PCR products were analyzed by electrophoresis on 
1.2% agarose gels containing 0.5 µg/ml ethidium bromide.  
In quantitative real-time PCR, the first-strand cDNA from 1.0 µg of each RNA 
sample was synthesized in a reaction volume of 20 µl at 42oC for 60 min by using 
QuantiTect® Reverse Transcription Kit (Qiagen), followed by real-time PCR 
amplification by using 0.1 µg of the first-strand cDNA, SYBR® Premix Ex Taq™ 
(Takara Bio, Japan), and MyiQ® Real-Time PCR Detection System (Bio-Rad) in a total 
volume of 15 µl. PCR cycling conditions were as follows: 95oC for 10 min, followed by 
40 cycles of 95oC for 15 sec, 55oC for 30 sec, and 72oC for 30 sec. The comparative 
∆∆CT method was used to quantify the gene expression levels, where 18s rRNA was 
used as an internal control for normalization, and IL-6 was used as the positive control. 
Relative fold changes in gene expression were calculated using the formula 2-∆∆Ct. 
Melting curve analysis (55-95oC) was performed and confirmed the amplification of a 
single product in each case. 
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CHAPTER IV 
 
RESULTS 
 
1. Determination of the optimal infective dose of M. haemolytica 
To be able to quantitate M. haemolytica in a liquid culture, we first obtained the 
bacterial growth curve and the correlation between OD600 and viable colony forming 
units (CFU) of the bacteria (Fig. 1) by using Graphpad prism (Graphpad software, San 
Diego, CA). A polynomial equation was further derived as follows: Y = 3.045 × 104 + 
3.434 × 106 × X + 1.329 ×109 × X2  - 2.263×109 × X3 + 1.912 × 109 × X4, where Y is the 
bacterial number (CFU/ml) and X is OD600. As a result, the number of live M. 
haemolytica in a liquid culture can be calculated directly from OD600.  
Next, both live and heat-inactivated bacteria were used to infect two bovine airway 
cell lines, namely BT and EBTr cells, at different bacteria:host cell rations in order to 
determine the optimal bacterial dose needed to elicit a robust immune response. IL-6 and 
IL-8, two commonly used proinflammatory cytokines that are known to be readily 
inducible under a variety of infectious conditions, were employed as positive indicators. 
Semi-quantitative RT-PCR was used to determine the expression levels of IL-6 and IL-8. 
As shown in Fig. 2, IL-6 was dose-dependently induced by 6 h challenge with both live 
and heat-inactivated bacteria in the two cell types. The same trend was also true with IL-8 
(data not shown). Because the strongest up-regulation occurred at the highest 
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bacteria:host cell ratio of 10:1, this infectious condition was maintained in the following 
large-scale experiments. 
 
2. Identification of inducible genes in response to infection with M. haemolytica  
SSH was performed to identify the genes that are induced following 6 h infection of 
BT and EBTr cells with live M. haemolytica on a genome scale. Because of a difficulty in 
isolating a sufficient amount of mRNA from cells for SSH, 1 µg of total RNA from each 
sample was used for cDNA synthesis and amplification by using the Super SMART PCR 
cDNA Synthesis Kit (Clontech).  To ensure amplification of cDNA products in the linear 
range, different cycles (15, 18, 21 and 24) were used for each sample. As shown in Fig. 
3A, 18-21 cycles were clearly around the linear range for all four samples. To further 
identify the optimal amplification cycles more accurately, another round of PCR was 
performed for different cycles in that range for each sample. The final PCR amplification 
cycles for control BT cells, infected BT cells, control EBTr cells, and infected EBTr cells 
were 21, 20, 20 and 19 cycles, respectively (Fig.3B).  
Optimally amplified PCR products were further size-separated through the 
CHROMA SPIN 1000 Columns (Clontech) and 1 ml fractions were collected separately. 
As indicated in Fig. 4, PCR products of large sizes were primarily concentrated in the 
fraction B, which therefore was saved for digestion with RsaI and ligation with adaptors. 
Uninfected control RNA samples prepared from two cell lines were used as drivers, 
whereas infected RNA samples were used as testers. Following two rounds of subtractive 
hybridization and PCR amplification, final PCR products were electrophoresed. A clear 
difference in the banding pattern was observed between subtracted and unsubtracted 
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samples (Fig. 5). To further analyze the efficiency of subtraction, a house-keeping gene, 
GAPDH, was PCR-amplified with subtracted and unsubtracted cDNAs for both cells for 
20, 25, 30 and 35 cycles. GAPDH levels were almost completely diminished even after 
35 cycles of amplification in subtracted samples as compared with unsubtracted samples 
(Fig. 6), clearly indicating a high efficiency of subtraction.  
Subtracted DNA samples were next ligated to pGEM-T Easy vector (Promega) and 
transformed into competent bacteria. A total of 288 white colonies were picked randomly 
for each cell type, and the sizes of all inserts were checked by colony PCR (Fig. 7). To 
facilitate the identification of inserts with different sizes, all PCR products were further 
rearranged according to their sizes. As shown in Fig. 8, all inserts varied greatly from 
<200 bp to >1200 bp, implying a good representation of different types of mRNAs. 
Ninety-six colonies with inserts of clearly different sizes were selected from each cell 
type for direct sequencing. 
A total of 62 cDNA products from BT cells and 74 inserts from EBTr cells returned 
readable sequences, which were subsequently searched for their homology with the 
GenBank database sequence using the BLAST program (Table1). These genes were 
further categorized based on their biological functions.  
As shown in Table 3, among a total of 51 non-redundant genes in the subtracted BT 
cell cDNA library, 35 were found to have hits in GenBank. Another 16 sequences did not 
return any good hits in GenBank, indicative of novel genes (data not shown). The genes 
with known functions can be further categorized into six groups, i.e., innate and adaptive 
immunity, cell adhesion and migration, general metabolism, transcriptional regulation 
and processing, signal transduction, and other known functions. For example, 46-kDa 
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collectin precursor (CL-46) is a C-type lectin involved in innate immunity [46, 47]. Prion 
protein (PRNP), causing the transmissible spongiform encephalopathies (TSEs) in 
humans and farm animals, was hypothesized recently as a new type of pattern recognition 
receptor for viruses, based on the homology in both function and structure [48, 49]. 
In the subtracted EBTr cell cDNA library, among a total of 65 non-redundant genes 
that have been identified, 39 genes have been identified with known functions by BLAST 
search of the GenBank (Table1 and Table 4). Interestingly, 15 bacterial genes were also 
identified (data not shown), which are likely to come from M. haemolytica adhered to 
EBTr cells or grown intracellularly. Another 26 sequences did not have any good hits, 
suggesting that they may be novel genes (data not shown). Among 18 genes with known 
functions, they can be assigned into three major groups, i.e., innate and adaptive 
immunity, signal transduction, and other known functions (Table 4).   
 
3. Identification of bovine lung-specific transcripts by SSH 
Bovine lung-specific transcripts were also identified similarly by SSH following 
subtraction of lung RNA samples from a mixture of an equal amount of RNA from heart, 
liver, muscle, colon, and rumen. A total of 88 inserts returned readable sequences, which 
were subsequently searched for their identities through the GenBank database using the 
BLAST program. A total of 61 genes were found to be non-redundant. Among them, 37 
genes were found to have hits in GenBank and can be classified in the following five 
groups, including innate and adaptive immunity, signal transduction, metabolism, DNA 
repair, and other genes known functions (Table1 and Table 5). The other 24 sequences 
are novel genes with no good hits (data not shown).   
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 4. Confirmation of the SSH results by RT-PCR  
To confirm the SSH results, semi-quantitative and real-time RT-PCR were further 
performed with 16 randomly selected genes. Among them, five genes were confirmed to 
be up-regulated following infections of BT and/or EBTr cells with M. haemolytica by 
semi-quantitative RT-PCR (Fig. 9). These five genes include sprouty homolog 4 (Spry4), 
COBW domain-containing protein 2 (CBWD2), endothelial cell-specific molecule 1 
(ESM1), CD164 (Endolyn), and a novel gene, G4. As expected, the positive control, IL-6 
gene, showed a robust induction following infections of both cell types (Fig. 9).  
Real-time RT-PCR was also independently used to confirm the expression of four 
selected genes, together with IL-6.  As shown in Fig. 10, IL-6 expression was 
dramatically increased in both cell types after infection. The expression levels of Nck-
associated protein 1 (Nap1), CD164, and G4 showed approximately 5-, 6-, and 4- fold 
changes, respectively, after 6-h infection of BT cells. Similarly, ESM1 also reached the 
maximum 5.6-fold induction after 12-h infection of BT cells. However, None of these 
four selected genes was found to be up-regulated in real-time PT-PCR in EBTr cells (Fig. 
10).
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CHAPTER V 
 
DISCUSSION 
 
The bovine respiratory disease (RBD) complex is the primary cause of economic loss 
in the beef and dairy cattle industry in North America. It’s believed that M. haemolytica 
is a major bacterial agent responsible for the BRD complex. However, the host defense 
mechanism against M. haemolytica remains poorly understood and, not surprisingly, 
there are no effective therapeutics available. To identify the host factors that are 
potentially involved in the bovine airway defense and resistance to M. haemolytica, SSH 
was employed to isolate bovine lung-specific genes as well as the genes induced in BT 
and EBTr cells following infection with M. haemolytica. 
Among a total of 224 genes with readable sequences identified from three subtracted 
cDNA libraries (BT cells, EBTr cells and lung), 177 were non-redundant. Among them, 
111 genes were found to have known functions and 66 were novel. In subtracted BT and 
EBTr cell cDNA libraries, a total of 74 sequences have been identified to have homology 
with known genes in GenBank, and 42 sequences were novel with unknown functions. In 
subtracted bovine lung cDNA library, 37 sequences were genes with known functions, 
while 24 genes were novel ones.  
Interestingly, sequencing of 96 clones from each of the subtracted BT and EBTr cell 
cDNA libraries revealed that most of the differentially expressed genes identified are 
different between the two cell types, expect for T cell receptor gamma and glutamate-
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cysteine ligase catalytic subunit (GCLC). Although BT and EBTr cells are both 
fibroblasts from bovine airway, the differential up-regulation profiles may reflect the fact 
that the difference in their anatomic locations where they are isolated. BT cells were 
derived from turbinate mucosa, whereas EBTr cells were from tracheal mucosa. 
Furthermore, different developmental stages of both cell types may also partially account 
for the discrepancy in the gene expression profile. BT cells were isolated from young, 
well-developed calves, while EBTr cells were originated from embryos. In fact, EBTr 
cells were found to be less responsive to M. haemolytica infection than BT cells in their 
ability to produce IL-6 (Fig. 2) or IL-8 (data not shown).  Nevertheless, it is expected that 
additional differentially expressed genes common in both cell types could be identified 
following sequencing of a larger number of colonies.  
Six were confirmed to be up-regulated in BT and/or EBTr cells following M. 
haemolytica infection as confirmed by semi-quantitative and/or real-time RT-PCR. These 
genes include endothelial cell-specific molecule 1 (ESM-1), CD164, sprouty homolog 4 
(Spry4), COBW domain-containing protein 2 (CBWD2), NCK-associated protein 1 
(Nap1), and a novel gene, G4.   
ESM-1 was recently found to specifically recognize and bind to integrin 
CD11a/CD18 on the cell surface of human blood lymphocytes and monocytes, which 
subsequently inhibits the interaction of integrin with the Intercellular Adhension 
Molecule-1 (ICAM-1) on the endothelial cells [50]. Interestingly, binding of leukotoxin 
(Lkt) of M. haemolytica to CD11/CD18 of β2-integrins of macrophages and neutrophils 
is a major cause of severe pulmonary lesions as observed in the BRD complex. An 
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increase in ESM-1 expression may play a protective role in the bovine airway by 
competitively inhibiting the binding of Lkt to β2-integrins on leukocytes.  
CD164 or endoly is a newly identified sialomucin with 2 extracellular mucin domains 
with expression on several cell types, including T cells, stromal cells, hematopoietic 
progenitor cells, and epithelial cells. CD164 functions in cell adhesion and migration and 
serves as a potent negative regulator of hematopoietic progenitor cell proliferation [51, 
52]. It is tempting to speculate that up-regulation of CD164 in response to M. 
haemolytica may limit epithelial cell proliferation and consequently bacterial spreading in 
the airway.  
Spry was firstly identified in Drosophila as an inhibitor of fibroblast growth factor 
(FGF) receptor and receptor tyrosine kinases (RTK) signal transduction. Among four 
Spry homologous proteins (Spry 1-4) identified in humans, Spry 4 functions as an 
antagonist of FGF receptor in lung development and inhibits the excessive tracheal 
branching in embryonic lung [53]. The impact on the up-regulation of Spry 4 in airway 
on pathogenesis of M. haemolytica remains unknown. 
Nap1, a GTP-binding protein (Rac)-interacting protein, was found recently to have a 
regulatory role in cell transformation, activation of c-Jun N-terminal kinases, and 
membrane NADPH oxidase [54]. The effect of the induction of Nap1 on airway defense 
and disease resistance is not known.  Similarly, the role of CBWD2, a cobalamin 
(vitamin B12) synthesis protein [55], in the host response to M. haemolytica remains 
unknown.  
Within 16 randomly selected genes, only six were found to be truly positive. The high 
frequency of false positives by SSH may be due to hybridization of the tester cDNA 
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samples with an insufficient amount of the driver cDNAs prior to PCR amplification of 
differentially expressed genes in the SSH procedure. Although the manufacturer 
recommends inclusion of the driver cDNA in 30-fold excess over the tester it seemed that 
this ratio could be changed to achieve better subtraction efficiency and reduce the 
frequency of the false positive results.  
 
Taken together, we have identified a diverse array of genes that are potentially 
induced in the bovine airway following M. haemolytica infection as well as the genes that 
are preferentially expressed in bovine lung. Among 16 randomly selected genes, six have 
been confirmed to be truly up-regulated in response to infection. Further studies are 
needed to study their role in disease resistance and/or pathogenesis. The expression 
patterns and functions of other identified genes, including 66 novel genes, will be 
investigated in the future as well. Moreover, such a collection of the airway genes can be 
potentially developed as a microarray tool for comprehensive transcriptional profiling of 
bovine host responses to infections with the BRD pathogens.  
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    Table 1.  Summary of the sequencing and BLAST results 
 
cDNA Library Clones screened 
Clones 
sequenced 
Readable 
sequences 
Non-
redundant 
genes 
Genes with 
known 
functions 
Novel 
genes 
BT cells 
(Up-regulated) 288 96 62 51 35 16 
EBTr cells 
(Up-regulated) 288 96 74 65 39* 26 
Lung-specific 
 288 96 88 61 37 24 
Total 864 288 224 177 111 66 
 
*Those 39 genes include 24 bovine genes and 15 bacterial genes. 
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Table 2.  Primers for semi-quantitative and real-time RT-PCR 
Target cDNA Primer Name Primer sequence (5’-3’) PCR product 
size (bp) 
Osteonectin bSPACRC-SN 
bSPACRC-AS 
CCTGTGACCTGGACAACGAC 
GTCAAAGAGAGAGAATCTGGT 
140 
B5 (Unknown gene) B5-EBTr-SN  
B5-EBTr-AS 
CCGTCTATGGGGTTGCACAG 
TGAGTAAGGAGAACTCTGGTG 
142 
NID67 (Unknown gene) bNID67-SN 
bNID67-AS 
AGACCTGGCACGATCCAGCA 
ATGACCCAGATGTCCAGGATG 
143 
Tumor protein, translationally-
controlled 1 (TPT1) 
bTPT1-SN  
bTPT1-AS
GGACTACCGTGAGGATGGTG 
CAGTAGCCAGCCAGTTATGAC
129 
Decorin (DCN) bDecorin-SN 
bDecorin-AS 
GACTGAGTTTCAACAGCATCT 
GAGCCGATTGCAGAGATATTG 
175 
Myeloid cell leukemia protein 
1 (MCL1) 
bMCL1-SN 
bMCL1-AS
CTTGAGCCTCTGAATGTGACC 
AAGGCTTAGAGATGGGCAGG
117 
CD47 bCD47-SN 
bCD47-AS 
GACTTGGTTTAATTGTACTTCC 
AGGACCATGCACTGGGATAC 
182 
Programmed cell death 4 bPDCD4-SN 
bPDCD4-AS 
CTGGATGTCCCACATTCATAC 
GCTCTCTGGTTTAAGACGACC 
156 
NCK-associated protein 1 
(NCKAP1) 
bNCKAP1-SN 
bNCKAP1-AS 
CTTGCATCCTCCAGTCTACT 
CATTTCTCAGCAAGACATAGG 
163 
COBW domain-containing 
protein 2 (CBWD2) 
bCBWD2-SN 
bCBWD2-AS 
GGAAGACGACAGTGAGAGAAC 
TGGACAAACTTGATCTTCTTGG 
145 
G4 (Unknown gene) G4-EBTr-SN 
G4-EBTr-AS 
GTCGTTGCTCTCATTACTATC 
GTCATAAGAAGCTGTGGCGAC 
130 
Prion Protein 
(PRNP) 
bPRNP-SN 
bPRNP-AS 
AAGTTCTTGGTGCAAATGTGTC 
GCTAAGGACAACACGGAAGAG 
108 
Sialomucin  (CD164) bCD164-SN 
bCD164-AS 
ACCACAACTCTGCCTTCCACT 
AGGTAGACTTCCGCGTAGGT 
106 
Ferritin heavy polypeptide 1  
(FTH1) 
bFTH1-SN 
bFTH1-AS 
AAGTGTGAATCAGTCACTACTG 
TTTGATGGCTTCCACCTGCTC 
115 
Sprouty homolog 4 bSPRY4-SN 
bSPRY4-AS 
TGCACTGGCCTTCTGGTTTATG 
CACCGACTTACCCACAGCAAAG 
110 
Endothelial cell-specific 
molecule 1 (ESM1) 
bESM1-SN 
bESM1-AS 
CAACAGGGTGACCGGCAAATG 
CCGTCTCCAGATGCCACGTC 
114 
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Table 3. M. haemolytica-induced genes in BT cells identified by SSH 
Best BLAST hit Identity (%) Score (bits) E value 
Innate and adaptive immunity    
46-kDa collectin precursor (CL-46) 92 (305/331) 450 7e-124 
Propreprion protein (PRNP) and prion-like 
protein doppel(PRND) 
93 (627/668) 985 0 
prion protein (PRNP) 96 (626/650) 1088 0 
T cell receptor gamma 98 (253/258) 466 2e-128 
Cell adhesion and migration    
Connective tissue growth factor 99 (369/372) 718 0 
Sialomucin  (CD164 antigen) 99 (296/297) 581 8e-163 
Fibronectin 1 94 (79/84) 137 6e-30 
Decorin 99 (399/403) 720 0 
Thymosin beta 4 100 (345/345) 630 1e-177 
Endothelial cell-specific molecule 1 (ESM1) 86 (87/101) 90 7e-15 
Prostaglandin E receptor 2 100 (64/64) 127 2e-26 
Prostaglandin E receptor 2 (subtype EP2), 
53kDa (PTGER2) 
100 (64/64) 127 2e-26 
General metabolism    
Glutamate-cysteine ligase catalytic subunit 
(GCLC) 
89 (157/176) 190 4e-45 
Low density lipoprotein receptor, transcript 
variant 6 
99 (174/175) 339 2e-90 
 
Ferritin heavy polypeptide 1 (FTH1) 99 (387/390) 708 0 
Phosphatidylinositol glycan class V 100 (35/35) 70 5e-09 
Transcriptional regulation and processing    
Splicing factor, proline-and glutamine-rich 90 (260/287) 315 7e-83 
Elongation of very long chain fatty acids -like 1 100 (416/416) 825 0 
Chromodomain helicase DNA binding protein 9 100 (81/81) 161 3e-36 
Signal transduction    
Sequestosome 1, transcript variant 3 99 (189/190) 369 3e-99 
Mus musculus sprouty homolog 4 93 (120/128) 198 1e-47 
Ras suppressor protein 1 (RSU1) 99 (519/520) 1023 0 
Moesin 99 (754/759) 1471 0 
90-kDa heat shock protein beta 92 (183/197) 299 2e-78 
Other genes with known functions     
Eukaryotic translation elongation factor 1 alpha 
1 (EEF1A1) 
100 (526/526) 1043 0 
Solute carrier family 35 member 3 (slc35a3) 93 (212/227) 331 2e-87 
Myostatin 96 (213/221) 377 3e-101 
X-inactivation center region, Jpx and Xist 95 (228/238) 377 1e-101 
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Mus musculus sprouty homolog 4 (Spry4) 93(120/128) 198 1e-47 
Genes with unknown functions    
CG10979-PA, transcript variant 1 100 (129/129) 256 9e-65 
Hypothetical LOC511583 95 (237/247) 410 9e-112 
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Table 4. M. haemolytica-induced genes in EBTr cells identified by SSH 
Best BLAST hit Identity (%) Score (bits) E value 
Innate and adaptive immunity     
T cell receptor gamma (TCRG) 96 (494/511) 882 0 
Apoptosis    
Programmed cell death 4 100 (336/336) 666 0 
General metabolism    
ATP synthase 99 (461/464) 896 0 
Glutamate-cysteine ligase catalytic subunit 
(GCLC) 
89 (157/176) 190 4e-45 
Decorin 100 (377/377) 706 0 
Signal transduction    
Sus scrofa myeloid cell leukemia protein 1 
(MCL1) 
86 (347/401) 285 1e-73 
Platelet-activating factor acetylhydrolase 99 (593/596) 1118 0 
NCK-associated protein 1 90 (38/42) 60 1e-5 
14-3-3 protein zeta/delta (protein 
kinase C inhibitor protein 1 
90 (188/208) 278 1e-71 
Zinc finger and BTB domain containing protein 99 (424/425) 835 0 
Progesterone membrane binding protein 96 (503/519) 934 0 
Other genes with known functions    
Osteonectin 99 (290/291) 571 9e-160 
Tumor protein, translationally-controlled 1 89 (364/406) 537 7e-150 
Sus scrofa topoisomersae II (TOPOII) 87 (341/389) 440 2e-120 
Actin, cytoplasmic 2 98 (713/727) 1352 0 
COBW domain-containing protein 2 99 (411/412) 809 0 
Tnni3 gene for cardiac troponin I 89 (161/179) 208 2e-50 
Homo sapiens v-myb myeloblastosis viral 
oncogene homolog (avian)-like 1 
89 (169/189) 210 2e-51 
Genes with unknown functions    
Homo sapiens cDNA clone IMAGE:3897094 91 (52/57) 70 7e-09 
Synthetic construct arsenic-like protein gene 97 (48/49) 92 2e-15 
Ornithine decarboxylase (ODC) 89 (94/105) 121 2e-24 
Bos taurus cDNA clone MGC:128424 
IMAGE:7954811 
98 (333/338) 634 5e-179 
Homo sapiens similar to hypothetical protein 
MGC17347 
87 (343/391) 379 4e-102 
Homo sapiens chromosome 2 open reading 
frame 12, transcript variant 1 (C2orf12) 
97 (271/278) 488 2e-134 
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Table 5.  Lung-specific genes identified by SSH 
 
Best BLAST hit Identity (%) Score 
(bits) 
E value 
Innate and adaptive immunity    
Amyloid β(A4) 98(296/299) 529 1e-149 
T cell receptor α 89(134/149) 176 4e-43 
Cell adhesion and migration    
Integrin α-3 precusor 99(538/542) 1043 0.0 
Chemokine ligand 16 100(160/160) 317 8e-86 
Cadherin 11 99(158/159) 307 5e-83 
Fibronectin 1 100(176/176) 349 2e-95 
Apoptosis    
RhoB 99(206/208) 317 9e-86 
Calpain 95(211/220) 383 2e-105 
Surfactant protein A (SP-A) 100 (23/23) 46 4e-4 
Surfactant, pulmonary-associated protein C 
(SFTPC) 
93 (154/164) 262 4e-69 
ATP-binding cassette sub-family E member 1 96 (764/789) 1372 0 
Signal transduction    
Caveolin 1 94(239/254) 406 1e-112 
Serum/glucocorticoid regulated kinase 98 (209/213) 398 2e-110 
Class I cytokine receptor 98(227/231) 432 3e-120 
AHNAK nucleoprotein isoform 1 98 (119/121) 228 6e-59 
Metabolism    
UDP-glucose dehydrogenase 98 (343/350) 607 8e-173 
Stearoyl-coenzyme A desaturase (SCD) 95 (369/387) 658 0 
Beta-1,2-N-acetylglucosaminyltransferase II 98 (306/312) 579 2e-164 
Adenosine deaminase (ADA) 99 (354/355) 698 0 
11-beta hydroxysteroid dehydrogenase type 2 100 (22/22) 44 0.006 
DNA repair    
APEX nuclease (multifunctional DNA repair 
enzyme) 1 
97 (415/425) 779 0 
Double-strand-break repair protein 99 (345/347) 674 0 
Transcriptional regulation    
Methyl-CpG binding domain protein 99 (251/252) 494 6e-139 
Other genes with known functions     
Futb and rtlf  83 (125/150) 88 2e-16 
Alpha-2-macroglobulin precursor 100 (486/486) 963 0 
Gap junction protein, alpha 5 99 (112/113) 216 7e-55 
Eukaryotic translation factor 5 95 (353/371) 620 7e-177 
Hypoxia-inducible factor 1 alpha  inhibitor 99 (155/156) 303 4e-81 
Transmembrane anchor protein 1 96 (192/196) 357 1e-97 
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Translocation protein 1 93 (260/279) 436 1e-121 
Polyribonucleotide nucleotidyltransferase 1 95 (104/109) 186 5e-46 
Sorting nexin 17 (SNX17) 100 (180/180) 357 1e-97 
Secretoglobin precursor 98 (240/244) 458 6e-128 
Chromodomain helicase DNA binding protein 8 99 (450/452) 884 0 
Beta-2-microglobulin (B2M) 94 (172/182) 301 4e-81 
SWI/SNF-related matrix-associated actin-
dependent regulator of chromatin a2 
100 (205/205) 406 1e-112 
Apolipoprotein L, 3 98 (104/106) 194 6e-49 
RNA-dependent helicase p68 88 (165/187) 238 4e-62 
Zinc finger, matrin type 2 99 (232/233) 454 1e-126 
RAN, member RAS oncogene family 100 (113/113) 224 1e-57 
Genes with unknown functions    
Hypothetical protein LOC613306 100 (246/246) 446 2e-124 
Cell surface retention sequence binding protein 1 96 (583/604) 1067 0 
Chromosome 17 open reading frame 27 93 (607/651) 969 0 
C10 protein 100 (32/32) 64 6e-9 
NudC domain containing 1 83 (180/216) 198 1e-49 
Ring finger protein 130  99 (285/287) 553 1e-156 
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Fig. 1. Growth curve of M. haemolytica.  Overnight bacterial culture was subcultured 
1:1000 and measured at OD600 for turbidity on an hourly basis. Each hourly bacterial 
culture was serially diluted and spread into medium agar plates for bacterial colony 
counting. 
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Fig. 2. Semi-quantitative RT-PCR Analysis of IL-6 mRNA expression in BT and 
EBTr cells following a 6-h infection with different doses of M. haemolytica.  BT cells 
were left uninfected (lane 1) or infected with live bacteria at bacteria:host cell ratios of 
1:1 (lane 2) and 10:1 (lane 3), whereas EBTr cells were left uninfected (lane 5) or 
infected with live bacteria at bacteria:host cell ratios of 0.1:1 (lane 6), 1:1 (lane 7), and 
10:1 (lane 8) or heated-inactivated bacteria at bacteria:host cell ratios of 0.1:1 (lane 9), 
1:1 (lane 10), 10:1 (lane 11), and 100:1 (lane 12). Total RNA was then isolated from each 
sample and subjected to semi-quantitative RT-PCR. PCR amplification cycles for 
GAPDH and IL-6 are 25 and 32 cycles, respectively. To facilitate visualization of PCR 
products, 100 bp DNA ladder was loaded in lane 4. 
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Fig. 4. Analysis of cDNA recovered from using BD CHROMA SPIN 1000 columns. 
Following linear amplification, cDNA samples were further fractionated by size-
exclusion chromatography. Lanes: 1, cDNA sample before chromatography; 2, eluted 
fraction B; 3, eluted fraction C; 4, eluted fraction D. To facilitate visualization of cDNA 
sizes, 100 bp ladder DNA marker and Lamda DNA/EcoR I + Hind III marker were 
loaded as well. 
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Fig. 6. Analysis of the subtraction efficiency. PCR was performed for 20, 25, 30, and 
35 cycles for both subtracted and unsubtracted cDNA samples from BT and EBTr cells. 
Note a significant reduction in GAPDH abundance in subtracted samples.  
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DNA ladder was loaded in the leftmost lane in each gel. 
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Fig. 10. Real-time RT-PCR confirmation of five M. haemolytica-induced genes 
identified by SSH. BT and EBTr cells were infected with M. haemolytica for 0, 1, 3, 6 
and 12 h, followed by RNA isolation and real-time RT-PCR for four different genes 
normalized against 18S rRNA expression.  IL-6 was used as a positive control.
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